In 2019, the Public Health Agency of Barcelona, Spain, was notified of a vaccine-derived poliovirus infection. The patient had an underlying common variable immunodeficiency and no signs of acute flaccid paralysis. We describe the ongoing coordinated response to contain the infection, which included compassionate-use treatment with pocapavir.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084499 | PMC |
http://dx.doi.org/10.3201/eid2705.204675 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!